朝聚眼科医疗控股有限公司（股票代码：02219）于2026年9月11日公告称，该公司于同日在香港联交所场内回购38,500股普通股，约占此前已发行股本的0.005%。本次回购的每股价格介乎每股2.47港元至2.515港元之间，合计耗资约9.62万港元。
公告显示，本次回购不会导致公司已发行股本及库藏股数发生变化。截至2026年9月11日，公司已发行股本总数为701,460,000股，库藏股数为0股。公司回购授权的批准日期为2026年5月12日，授权可回购股份总数为70,518,050股，累计已于香港联交所或其他证券交易所回购5,117,500股，占授权时公司已发行股本数目的约0.726%。
公司确认已按香港联合交易所有限公司证券上市规则及相关法律法规的规定和要求进行本次股份回购。公告由执行董事兼联席公司秘书张光弟签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.